Navaneel Kar Appointed as Director General of IPM India

Business by 2FIRSTS.ai
Jan.12.2024
Navaneel Kar Appointed as Director General of IPM India
Philip Morris International (PMI) has appointed Navaneel Kar as the Managing Director of its Indian subsidiary IPM India.

According to international media reports, Philip Morris International has appointed Navaneel Kar as the Managing Director of its Indian subsidiary, IPM India.

 

Prior to this, Karl served as the Sales President at Tata Consumer Products. He will report directly to Ankur Modi, the Cluster Head for South Asia and Indochina.

 

Carl has over 25 years of professional experience and has worked for renowned brands such as ITC and Tata Motors in India. He has successfully led teams and organizations in various categories and channels within the food, tobacco, personal care, and beverage sectors.

 

Indian Prime Minister Narendra Modi said in a statement, "I am pleased to welcome Navaneel Kaul as the Managing Director of IPM India. Kaul has demonstrated outstanding leadership and competence throughout his career. His entrepreneurial spirit and learning mindset will be crucial for propelling our Indian business into the next phase of growth.

 

Carl said: "I am thrilled to take on this new position at such an exciting moment and contribute to the company's growth and overall success. I am looking forward to working with the team, leveraging our competitive advantage, and simultaneously fostering an inclusive, diverse, and progressive work environment.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | 60,000 Puffs & Adjustable Settings: UWELL KOKO BAR 60K ICE Launches in U.S.
Product | 60,000 Puffs & Adjustable Settings: UWELL KOKO BAR 60K ICE Launches in U.S.
E-cigarette brand UWELL has launched the KOKO BAR 60K ICE disposable vape, offering 60,000 puffs with six levels of cooling intensity and five levels of nicotine strength adjustment, plus a 3D curved display. Now available on U.S. retailer websites at around $17.99.
Jul.14 by 2FIRSTS.ai
Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada stated that one year ago, the government removed the nicotine pouch ZONNIC from convenience stores, restricting sales to behind-the-counter in pharmacies. This move caused ZONNIC sales to plummet, cigarette sales to rebound by 2.8%, and was accompanied by a surge of high-dose illegal nicotine pouches and black-market cigarettes (exceeding 500 million packs annually). The company is calling for an evidence-based harm reduction approach to restore multi-channel supply throu
Aug.20 by 2FIRSTS.ai
Special Report | Russian Government Hesitates to Choke Revenue Stream with Vape Sales Ban
Special Report | Russian Government Hesitates to Choke Revenue Stream with Vape Sales Ban
Caught between banning and not banning, the Russian government finds itself in a dilemma. The vape market generates substantial tax revenue, yet raises public health concerns. Lawmakers are applying pressure—some even suggest “following China”—as a regulatory storm quietly gathers.
Aug.22
Singapore Cracks Down on Vaping: Over 3,700 Offenders Caught Between April and June
Singapore Cracks Down on Vaping: Over 3,700 Offenders Caught Between April and June
Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) announced that more than 3,700 people were caught and fined for possessing or using vapes between April and June 2024, marking a nearly 20% increase from the previous quarter. Authorities have intensified enforcement at military camps, training schools, and border checkpoints, while imposing tougher actions on cases involving “Kpods” laced with etomidate.
Aug.27 by 2FIRSTS.ai
FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance
FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance
FDA Commissioner Robert Califf urged the DEA to classify 7-OH, an opioid-like compound found in vapes, drinks, and gummies, as a Schedule I substance. The FDA plans national warnings for doctors and tighter control of high concentrations.
Jul.30 by 2FIRSTS.ai
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai